These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6142350)

  • 21. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J; Gao H; Jin SX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthyroidism with potent thyroid-stimulation-blocking antibodies and negative thyroid-stimulating antibodies after subtotal thyroidectomy for Graves' disease with follicular thyroid carcinoma.
    Sugimoto M; Nakamura S; Hattori J; Yamada T; Horiya Y; Hara S; Shima H
    Intern Med; 1993 Mar; 32(3):266-8. PubMed ID: 8101110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
    Teng CS; Yeung RT
    J Clin Endocrinol Metab; 1980 Jan; 50(1):144-7. PubMed ID: 6892512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
    Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbimazole and the autoimmune response in Graves' disease.
    McGregor AM; Petersen MM; McLachlan SM; Rooke P; Smith BR; Hall R
    N Engl J Med; 1980 Aug; 303(6):302-7. PubMed ID: 6247656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases.
    Bech K; Nistrup Madsen S
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):47-58. PubMed ID: 583261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies.
    Atkinson S; Kendall-Taylor P
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1263-6. PubMed ID: 6117567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease.
    Massart C; Hody B; Mouchel L; Edan G; Nicol M
    Clin Chem; 1986 Jul; 32(7):1332-5. PubMed ID: 2872980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid-stimulating antibodies in patients with autoimmune disorders.
    Strakosch CR; Joyner D; Wall JR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism.
    Shigemasa C; Shirota K; Urabe K; Kouchi T; Mitani Y; Ueta Y; Yoshida A; Mashiba H
    Horm Res; 1991; 35(5):208-12. PubMed ID: 1687041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay.
    Smyth PP; Neylan D; O'Donovan DK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):357-61. PubMed ID: 6119323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The assay of Graves' immunoglobulins: a comparison of different methods.
    Hardisty CA; Kendall-Taylor P; Atkinson S; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):637-44. PubMed ID: 6136348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pre-operative potassium iodide therapy on antibody production.
    Wilson R; McKillop JH; Thomson JA
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):531-4. PubMed ID: 1979466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of Graves' disease and papillary thyroid carcinoma with predominant production of thyroid-stimulation-blocking antibodies (TSBAb) persisted after total thyroidectomy.
    Nakamura S; Ishiyama-Takuno M; Kosaka J; Kondo K; Horiya Y; Hara S; Shima H; Shiraki T
    Endocrinol Jpn; 1992 Feb; 39(1):133-9. PubMed ID: 1351465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid stimulating antibodies in patients with Graves' ophthalmopathy.
    Gomez JM; Soler J; Navarro MA
    Thyroidology; 1991 May; 3(2):59-61. PubMed ID: 1726901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunology of the thyrotropin receptor.
    Smith BR
    Immunol Commun; 1976; 5(5):345-60. PubMed ID: 61168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.